Cibisatamab
- Generic Name
- Cibisatamab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2101242-53-7
- Unique Ingredient Identifier
- ZAM5J1ATF2
- Associated Conditions
- -
- Associated Therapies
- -
Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Phase 1
Completed
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 54
- Registration Number
- NCT04826003
- Locations
- 🇩🇰
Rigshospitalet, København Ø, Denmark
🇪🇸Clinica Universitaria de Navarra, Pamplona, Navarra, Spain
🇪🇸Hospital del Mar, Barcelona, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath